Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment-Reference-Cited by-同舟云学术

Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment

Published:2018-11 Issue:11 Volume:62 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Alfarisi Omamah¹,Mave Vidya¹²,Gaikwad Sanjay³,Sahasrabudhe Tushar⁴,Ramachandran Geetha⁵,Kumar Hemanth⁵,Gupte Nikhil¹²,Kulkarni Vandana²,Deshmukh Sona²,Atre Sachin⁴,Raskar Swapnil²,Lokhande Rahul³,Barthwal Madhusudan⁴,Kakrani Arjun⁴,Chon Sandy¹,Gupta Amita¹²,Golub Jonathan E.¹,Dooley Kelly E.¹

Affiliation:

1. Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

2. Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, India

3. Byramjee Jeejeebhoy Government Medical College, Pune, India

4. Dr. D. Y. Patil Medical College, Hospital and Research Center, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, India

5. National Institute for Research in Tuberculosis, Chennai, India

Abstract

Diabetes mellitus (DM) and tuberculosis (TB) are two common diseases with increasing geographic overlap and clinical interactions. The effect of DM and hemoglobin A1c (HbA1c) values on the pharmacokinetics (PK) and pharmacodynamics (PD) of anti-TB drugs remains poorly characterized.

Funder

HHS | National Institutes of Health

HHS | NIH | Fogarty International Center

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01383-18

Reference72 articles.

1. World Health Organization. 2017. Global tuberculosis report 2017. World Health Organization Geneva Switzerland. http://www.who.int/tb/publications/global_report/en/. Accessed 3 May 2018.

2. World Health Organization. 2017. Diabetes. World Health Organization Geneva Switzerland. http://www.who.int/en/news-room/fact-sheets/detail/diabetes. Accessed 3 May 2018.

3. Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis

4. Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review

5. Diabetic Control and Risk of Tuberculosis: A Cohort Study

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shared challenges to the control of complex intracellular neglected pathogens;Frontiers in Public Health;2024-09-11

2. A systematic review on the effect of diabetes mellitus on the pharmacokinetics of TB drugs;The International Journal of Tuberculosis and Lung Disease;2024-09-01

3. Pharmacokinetics-pharmacodynamics of first line antitubercular drugs: A comparative study in tuberculosis patients with and without concomitant diabetes mellitus;2024-08-17

4. Drug Exposure and Treatment Outcomes in Patients With Multidrug-Resistant Tuberculosis and Diabetes Mellitus: A Multicenter Prospective Cohort Study From China;Clinical Infectious Diseases;2024-06-24

5. Tuberculosis-diabetes comorbidities: Mechanistic insights for clinical considerations and treatment challenges;World Journal of Diabetes;2024-05-15